Solution structure and dynamics of the chimeric SH3 domains, SHH- and SHA-"Bergeracs"

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 12, 2009, Pages 1813-1822

  Kutyshenko, Victor P ^a   Prokhorov, Dmitry A ^a   Timchenko, Maria A ^a   Kudrevatykh, Yuri A ^a   Gushchina, Liubov' V ^b   Khristoforov, Vladimir S ^a   Filimonov, Vladimir V ^b   Uversky, Vladimir N ^c,d  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

Flexibility; High resolution NMR; Intrinsic disorder; PONDR; Protein dynamics; Protein folding

Indexed keywords

CHIMERIC PROTEIN; POLYPEPTIDE; PROTEIN SH3; SHA PROTEIN; SHH PROTEIN; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PREDICTION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SOLUTIONS; SRC HOMOLOGY DOMAINS; THERMODYNAMICS;

EID: 73049097841     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.08.021     Document Type: Article

References (81)

1. Nolting B. Methods in Modern Biophysics (2004), Springer-Verlag, Berlin, Heidelberg
2. Mittermaier A., Korzhnev D.M., and Kay L.E. Side-chain interactions in the folding pathway of a Fyn SH3 domain mutant studied by relaxation dispersion NMR spectroscopy. Biochemistry 44 (2005) 15430-15436
3. Li J., Shinjo M., Matsumura Y., Morita M., Baker D., Ikeguchi M., and Kihara H. An alpha-helical burst in the Src SH3 folding pathway. Biochemistry 46 (2007) 5072-5082
4. Musacchio A., Gibson T., Lehto V.P., and Saraste M. SH3-an abundant protein domain in search of a function. FEBS Lett. 307 (1992) 55-61
5. Gmeiner W.H., and Horita D.A. Implications of SH3 domain structure and dynamics for protein regulation and drug design. Cell Biochem. Biophys. 35 (2001) 127-140
6. Kay B.K., Williamson M.P., and Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14 (2000) 231-241
7. Mayer B.J. SH3 domains: complexity in moderation. J. Cell. Sci. 114 (2001) 1253-1263
8. Cowan-Jacob S.W. Structural biology of protein tyrosine kinases. Cell Mol. Life Sci. 63 (2006) 2608-2625
9. Viguera A.R., Arrondo J.L., Musacchio A., Saraste M., and Serrano L. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 33 (1994) 10925-10933
10. Pisabarro M.T., and Serrano L. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain. Biochemistry 35 (1996) 10634-10640
11. Arold S.T., Ulmer T.S., Mulhern T.D., Werner J.M., Ladbury J.E., Campbell I.D., and Noble M.E. The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases. J. Biol. Chem. 276 (2001) 17199-17205
12. Musacchio A. How SH3 domains recognize proline. Adv. Protein Chem. 61 (2002) 211-268
13. Musacchio A., Wilmanns M., and Saraste M. Structure and function of the SH3 domain. Prog. Biophys. Mol. Biol. 61 (1994) 283-297
14. Viguera A.R., and Serrano L. Bergerac-SH3: "frustration" induced by stabilizing the folding nucleus. J. Mol. Biol. 311 (2001) 357-371
15. Dunker A.K., Garner E., Guilliot S., Romero P., Albrecht K., Hart J., Obradovic Z., Kissinger C., and Villafranca J.E. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomput. (1998) 473-484
16. Romero P., Obradovic Z., Kissinger C.R., Villafranca J.E., Garner E., Guilliot S., and Dunker A.K. Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput. (1998) 437-448
17. Wright P.E., and Dyson H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293 (1999) 321-331
18. Uversky V.N., Gillespie J.R., and Fink A.L. Why are "natively unfolded": proteins unstructured under physiologic conditions?. Proteins 41 (2000) 415-427
19. Dunker A.K., Lawson J.D., Brown C.J., Williams R.M., Romero P., Oh J.S., Oldfield C.J., Campen A.M., Ratliff C.M., Hipps K.W., Ausio J., Nissen M.S., Reeves R., Kang C., Kissinger C.R., Bailey R.W., Griswold M.D., Chiu W., Garner E.C., and Obradovic Z. Intrinsically disordered protein. J. Mol. Graph. Model 19 (2001) 26-59
20. Dunker A.K., and Obradovic Z. The protein trinity-linking function and disorder. Nat. Biotechnol. 19 (2001) 805-806
21. Tompa P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27 (2002) 527-533
22. Dunker A.K., Brown C.J., Lawson J.D., Iakoucheva L.M., and Obradovic Z. Intrinsic disorder and protein function. Biochemistry 41 (2002) 6573-6582
23. Dunker A.K., Brown C.J., and Obradovic Z. Identification and functions of usefully disordered proteins. Adv. Protein Chem. 62 (2002) 25-49
24. Iakoucheva L.M., Brown C.J., Lawson J.D., Obradovic Z., and Dunker A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323 (2002) 573-584
25. Uversky V.N. Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 11 (2002) 739-756
26. Uversky V.N. What does it mean to be natively unfolded?. Eur. J. Biochem. 269 (2002) 2-12
27. Uversky V.N. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go?. Cell Mol. Life Sci. 60 (2003) 1852-1871
28. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12 (2002) 54-60
29. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15 (2005) 35-41
30. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell. Biol. 6 (2005) 197-208
31. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 579 (2005) 3346-3354
32. Dunker A.K., Cortese M.S., Romero P., Iakoucheva L.M., and Uversky V.N. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 272 (2005) 5129-5148
33. Uversky V.N., Oldfield C.J., and Dunker A.K. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18 (2005) 343-384
34. Radivojac P., Iakoucheva L.M., Oldfield C.J., Obradovic Z., Uversky V.N., and Dunker A.K. Intrinsic disorder and functional proteomics. Biophys. J. 92 (2007) 1439-1456
35. Sickmeier M., Hamilton J.A., LeGall T., Vacic V., Cortese M.S., Tantos A., Szabo B., Tompa P., Chen J., Uversky V.N., Obradovic Z., and Dunker A.K. DisProt: the database of disordered proteins. Nucleic Acids Res. 35 (2007) D786-793
36. Le Gall T., Romero P.R., Cortese M.S., Uversky V.N., and Dunker A.K. Intrinsic disorder in the Protein Data Bank. J. Biomol. Struct. Dyn. 24 (2007) 325-342
37. Vucetic S., Xie H., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Obradovic Z., and Uversky V.N. Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. J. Proteome. Res. 6 (2007) 1899-1916
38. Xie H., Vucetic S., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Obradovic Z., and Uversky V.N. Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. J. Proteome. Res. 6 (2007) 1917-1932
39. Xie H., Vucetic S., Iakoucheva L.M., Oldfield C.J., Dunker A.K., Uversky V.N., and Obradovic Z. Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. J. Proteome. Res. 6 (2007) 1882-1898
40. Cortese M.S., Uversky V.N., and Keith Dunker A. Intrinsic disorder in scaffold proteins: getting more from less. Prog. Biophys. Mol. Biol. 98 (2008) 85-106
41. Dunker A.K., Oldfield C.J., Meng J., Romero P., Yang J.Y., Chen J.W., Vacic V., Obradovic Z., and Uversky V.N. The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 9 Suppl. 2 (2008) S1
42. Dunker A.K., Silman I., Uversky V.N., and Sussman J.L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 18 (2008) 756-764
43. Dunker A.K., and Uversky V.N. Signal transduction via unstructured protein conduits. Nat. Chem. Biol. 4 (2008) 229-230
44. Fuxreiter M., Tompa P., Simon I., Uversky V.N., Hansen J.C., and Asturias F.J. Malleable machines take shape in eukaryotic transcriptional regulation. Nat. Chem. Biol. 4 (2008) 728-737
45. Uversky V.N., Oldfield C.J., and Dunker A.K. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 37 (2008) 215-246
46. Vacic V., Uversky V.N., Dunker A.K., and Lonardi S. Composition Profiler: a tool for discovery and visualization of amino acid composition differences. BMC Bioinformatics 8 (2007) 211
47. Campen A., Williams R.M., Brown C.J., Meng J., Uversky V.N., and Dunker A.K. TOP-IDP-scale: a new amino acid scale measuring propensity for intrinsic disorder. Protein Pept. Lett. 15 (2008) 956-963
48. Ferron F., Longhi S., Canard B., and Karlin D. A practical overview of protein disorder prediction methods. Proteins 65 (2006) 1-14
49. Dosztanyi Z., Sandor M., Tompa P., and Simon I. Prediction of protein disorder at the domain level. Curr. Protein Pept. Sci. 8 (2007) 161-171
50. Dosztanyi Z., and Tompa P. Prediction of protein disorder. Methods Mol. Biol. 426 (2008) 103-115
51. Li L., Uversky V.N., Dunker A.K., and Meroueh S.O. A computational investigation of allostery in the catabolite activator protein. J. Am. Chem. Soc. 129 (2007) 15668-15676
52. Liang S., Li L., Hsu W.-L., Zhou Y., Dunker A.K., Uversky V.N., and Meroueh S.O. Exploring the molecular design of protein interaction sites with molecular dynamics simulations and free energy calculations. Biochemistry 48 (2008) 399-414
53. Viguera A.R., and Serrano L. Hydrogen-exchange stability analysis of Bergerac-Src homology 3 variants allows the characterization of a folding intermediate in equilibrium. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5730-5735
54. Peranen J., Rikkonen M., Hyvonen M., and Kaariainen L. T7 vectors with a modified T7lac promoter for expression of proteins in Escherichia coli. Anal. Biochem. 236 (1996) 371-373
55. Viguera A.R., Serrano L., and Wilmanns M. Different folding transition states may result in the same native structure. Nat. Struct. Biol. 3 (1996) 874-880
56. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326
57. Keller R. The Computer Aided Resonance Assignment Tutorial, 1 ed. (2004), Cantina Verlag, Goldau, Switzerland
58. Sattler M., Schleucher J., and Griesinger C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Mag. Res. Sp. 34 (1999) 93-158
59. Markley J.L., Bax A., Arata Y., Hilbers C.W., Kaptein R., Sykes B.D., Wright P.E., and Wuthrich K. Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the standardization of data bases of protein and nucleic acid structures determined by NMR spectroscopy. J. Biomol. NMR 12 (1998) 1-23
60. Wishart D.S., Bigam C.G., Yao J., Abildgaard F., Dyson H.J., Oldfield E., Markley J.L., and Sykes B.D. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6 (1995) 135-140
61. Farrow N.A., Muhandiram R., Singer A.U., Pascal S.M., Kay C.M., Gish G., Shoelson S.E., Pawson T., Forman-Kay J.D., and Kay L.E. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33 (1994) 5984-6003
62. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
63. Orekhov V.Y., Nolde D.E., Golovanov A.P., Korzhnev D.M., and Arseniev A.S. Processing of heteronuclear NMR relaxation data with the new software DASHA. Appl. Magn. Reson. 9 (1995) 581-588
64. Cornilescu G., Delaglio F., and Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13 (1999) 289-302
65. Guntert P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278 (2004) 353-378
66. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph 14 51-55 (1996) 29-32
67. Baxter N.J., and Williamson M.P. Temperature dependence of 1H chemical shifts in proteins. J. Biomol. NMR 9 (1997) 359-369
68. Peng K., Radivojac P., Vucetic S., Dunker A.K., and Obradovic Z. Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics 7 (2006) 208
69. Musacchio A., Noble M., Pauptit R., Wierenga R., and Saraste M. Crystal structure of a Src-homology 3 (SH3) domain. Nature 359 (1992) 851-855
70. Prokhorov D.A., Timchenko M{cyrillic}.A., Kudrevatykh Y.A., Fedyukina D.V., Gushchina L.V., Khristoforov V.S., Filimonov V.V., and Kutyshenko V.P. Study of the structure and dynamics of a chimerical variant of the SH3 domain (SHA-Bergerac) by NMR spectroscopy,. Russian Journal of Bioorganic Chemistry 34 (2008) 578-585
71. Viguera A.R., Martinez J.C., Filimonov V.V., Mateo P.L., and Serrano L. Thermodynamic and kinetic analysis of the SH3 domain of spectrin shows a two-state folding transition. Biochemistry 33 (1994) 2142-2150
72. Noble M.E., Musacchio A., Saraste M., Courtneidge S.A., and Wierenga R.K. Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 12 (1993) 2617-2624
73. Blanco F.J., Ortiz A.R., and Serrano L. 1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure. J. Biomol. NMR 9 (1997) 347-357
74. Hiroaki H., Klaus W., and Senn H. Determination of the solution structure of the SH3 domain of human p56 Lck tyrosine kinase. J. Biomol. NMR 8 (1996) 105-122
75. Ortega Roldan J.L., Romero Romero M.L., Ora A., Ab E., Lopez Mayorga O., Azuaga A.I., and van Nuland N.A. The high resolution NMR structure of the third SH3 domain of CD2AP. J. Biomol. NMR 39 (2007) 331-336
76. Kay L.E., Torchia D.A., and Bax A. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. Biochemistry 28 (1989) 8972-8979
77. Daragan V.A., and Mayo K.H. Motional model analyses of protein and peptide dynamics using C-13 and N-15 NMR relaxation. Prog. Nucl. Mag. Res. Sp. 31 (1997) 63-105
78. Lipari G., and Szabo A. Model-free approach o the interpretation of nuclear magnetic relaxation in macromolecules. 1. Theory and range of validity. J. Am. Chem. Soc. 104 (1982) 4559-4570
79. Clore G.M., Szabo A., Bax A., Kay L.E., Driscoll P.C., and Gronenborn A.M. Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins. J. Am. Chem. Soc 112 (1990) 4989-4991
80. Gushchina L.V., Gabdulkhakov A.G., Nikonov S.V., Mateo P.L., and Filimonov V.V. Structural and thermodynamic studies of Bergerac-SH3 chimeras. Biophys. Chem. 139 (2009) 106-115
81. Wuthrich K. NMR in Biological Research: Peptides and Proteins (1976), North-Hold Publishing Company, Amsterdam, Oxford